1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Chronic Disease Analysis & Statistics in Spain, January 2020

Chronic Disease Analysis & Statistics in Spain, January 2020

1-30 of about 100 reports

Spain Respiratory Diseases Diagnostic Testing Market, 2019-2023: Supplier Shares by Test, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Instrumentation Review, Opportunities for Suppliers

Spain Respiratory Diseases Diagnostic Testing Market, 2019-2023: Supplier Shares by Test, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Instrumentation Review, Opportunities for Suppliers

  • $ 1250
  • Industry report
  • July 2019

Spain Respiratory Diseases Diagnostic Testing Market, 2019-2023: Supplier Shares by Test, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Instrumentation Review, Opportunities ...

  • Industries : Medical Biotechnology, Diagnostics, In Vitro Diagnostics, In Vitro Diagnostics
  • Countries : Spain
Spain Diabetes Market Report: 2019-2024

Spain Diabetes Market Report: 2019-2024

  • $ 1999
  • Industry report
  • June 2019

the analyst’s new report “Spain Diabetes Market Report: 2019 - 2024” provides an analytical and statistical insight into the Spain diabetes market.The report provides both current and future trends ...

  • Industries : Chronic Disease, Pathology
  • Countries : Spain
2019 Spain Respiratory Diseases Diagnostic Testing Market: Supplier Shares by Test, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Instrumentation Review, Opportunities for Suppliers

2019 Spain Respiratory Diseases Diagnostic Testing Market: Supplier Shares by Test, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Instrumentation Review, Opportunities for Suppliers

  • $ 1850
  • Industry report
  • April 2019

2019 Spain Respiratory Diseases Diagnostic Testing Market: Supplier Shares by Test, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Instrumentation Review, Opportunities ...

  • Industries : Medical Biotechnology, Diagnostics, In Vitro Diagnostics, In Vitro Diagnostics, Healthcare
  • Countries : Spain
2019-2023 Competing in the Spain Respiratory Diseases Diagnostic Testing Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

2019-2023 Competing in the Spain Respiratory Diseases Diagnostic Testing Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

  • $ 1950
  • Industry report
  • March 2019

2019-2023 Competing in the Spain Respiratory Diseases Diagnostic Testing Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and ...

  • Industries : Diagnostics, Medical Biotechnology, In Vitro Diagnostics, In Vitro Diagnostics, Healthcare
  • Countries : Spain
2018 Spain Respiratory Diseases Diagnostic Testing Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

2018 Spain Respiratory Diseases Diagnostic Testing Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

  • $ 1250
  • Industry report
  • June 2018

About This ReportThis new 281-page report .com presents detailed analysis of the Spanish Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, ...

  • Industries : Diagnostics, Medical Biotechnology, In Vitro Diagnostics, In Vitro Diagnostics, Healthcare
  • Countries : Spain
Almirall S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Almirall S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • May 2018

Almirall S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportSummaryMarketline’s Almirall S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report ...

  • Industries : Health Services, Pharmaceutical, Therapy, Pathology
  • Countries : Spain
Europe Blood Glucose Device Market, Forecast SMBG Components (Test Strips, Lancet, Meter), Diabetes Population (Type 1 & 2)

Europe Blood Glucose Device Market, Forecast SMBG Components (Test Strips, Lancet, Meter), Diabetes Population (Type 1 & 2)

  • $ 1290
  • Industry report
  • April 2018

Self-Monitoring Blood Glucose (SMBG) device market is providing big business opportunities for device manufactures in the Europe.It is projected that Europe Blood Glucose Device market will climb to nearly ...

  • Industries : Chronic Disease, Pathology, Patient Monitoring, Medical Device
  • Countries : Western Europe, Northern Europe, Scandinavia, Europe, Southern Europe, World, United Kingdom, Russia, Germany, Netherlands, Italy, Sweden, Spain
Osteoporosis: Epidemiology Forecast to 2027

Osteoporosis: Epidemiology Forecast to 2027

  • $ 3995
  • Industry report
  • April 2018

Osteoporosis: Epidemiology Forecast to 2027SummaryOsteoporosis is a disease in which the density and quality of bone are reduced over time.In a normal process known as remodeling, some of a person’s ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States, Japan, Germany, Spain, World, Italy, France
EpiCast Report: Painful Diabetic Neuropathy - Epidemiology Forecast to 2026

EpiCast Report: Painful Diabetic Neuropathy - Epidemiology Forecast to 2026

  • $ 3995
  • Industry report
  • January 2018

EpiCast Report: Painful Diabetic Neuropathy - Epidemiology Forecast to 2026SummaryDiabetic neuropathy is a long-term complication of diabetes mellitus (DM). Diabetic patients may, over time, develop this ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States, World, Japan, Spain
Almirall S.A. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Almirall S.A. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • December 2017

Almirall S.A. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportSummaryMarketline’s Almirall S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments ...

  • Industries : Health Services, Pharmaceutical, Therapy, Pathology
  • Countries : Spain
EU5 Immuno Chemistry Market Outlook to 2024

EU5 Immuno Chemistry Market Outlook to 2024

  • $ 5995
  • Industry report
  • December 2017

EU5 Immuno Chemistry Market Outlook to 2024SummaryGlobalData’s new report, EU5 Immuno Chemistry Market Outlook to 2024, provides key market data on the EU5 Immuno Chemistry market. The report provides ...

  • Industries : Medical Device, Diagnostics, In Vitro Diagnostics, In Vitro Diagnostics, Health Services, Pathology, Healthcare, Chronic Disease, Patient Monitoring
  • Countries : Southern Europe, Western Europe, United Kingdom, Spain, Italy, France, Germany, Northern Europe
EpiCast Report: Chronic Kidney Disease - Epidemiology Forecast to 2026

EpiCast Report: Chronic Kidney Disease - Epidemiology Forecast to 2026

  • $ 3995
  • Industry report
  • December 2017

EpiCast Report: Chronic Kidney Disease - Epidemiology Forecast to 2026SummaryChronic kidney disease (CKD), or chronic renal disease, is an asymptomatic, long-term condition that damages the kidneys and ...

  • Industries : Chronic Disease, Health Services
  • Countries : United Kingdom, United States, World, Japan, Spain, Germany
Spain In Vitro Diagnostics (IVD) Market Outlook to 2024 - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

Spain In Vitro Diagnostics (IVD) Market Outlook to 2024 - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

  • $ 5995
  • Industry report
  • December 2017

Spain In Vitro Diagnostics (IVD) Market Outlook to 2024 - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology CultureSumm ...

  • Industries : Diagnostics, In Vitro Diagnostics, In Vitro Diagnostics, Medical Device, Healthcare
  • Countries : Spain, Southern Europe
Spain Immuno Chemistry Market Outlook to 2024

Spain Immuno Chemistry Market Outlook to 2024

  • $ 4995
  • Industry report
  • November 2017

Spain Immuno Chemistry Market Outlook to 2024SummaryGlobalData’s new report, Spain Immuno Chemistry Market Outlook to 2024, provides key market data on the Spain Immuno Chemistry market. The report provides ...

  • Industries : Diagnostics, In Vitro Diagnostics, In Vitro Diagnostics, Medical Device
  • Countries : Spain
EpiCast Report: Macular Edema - Epidemiology Forecast to 2026

EpiCast Report: Macular Edema - Epidemiology Forecast to 2026

  • $ 3995
  • Industry report
  • November 2017

EpiCast Report: Macular Edema - Epidemiology Forecast to 2026SummaryMacular edema (ME) is a condition characterized by the thickening and swelling (edema) of the macula, which is the area of the retina ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States, Spain, Germany, Japan, Italy, France, United Kingdom
EpiCast Report: Pulmonary Arterial Hypertension - Epidemiology Forecast to 2026

EpiCast Report: Pulmonary Arterial Hypertension - Epidemiology Forecast to 2026

  • $ 3995
  • Industry report
  • October 2017

EpiCast Report: Pulmonary Arterial Hypertension - Epidemiology Forecast to 2026SummaryPulmonary arterial hypertension (PAH) is a rare and severe condition characterized by vascular proliferation and remodeling ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States, Japan, Germany, France, Spain
EpiCast Report: Osteoarthritis - Epidemiology Forecast to 2026

EpiCast Report: Osteoarthritis - Epidemiology Forecast to 2026

  • $ 3995
  • Industry report
  • September 2017

EpiCast Report: Osteoarthritis - Epidemiology Forecast to 2026SummaryOsteoarthritis (OA) is a gradually progressive joint disease that is typically seen in middle-aged to elderly people. According to the ...

  • Industries : Chronic Disease
  • Countries : United States, Japan, Spain
PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2026

PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2026

  • $ 10995
  • Industry report
  • July 2017

PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2026SummaryType 2 diabetes (T2D) is a chronic disease characterized by insulin resistance and pancreatic ?-cell failure, with ...

  • Industries : Chronic Disease, Pathology, Therapy
  • Countries : United States, Western Europe, Southern Europe, Japan, Germany, North America, World, Italy, Spain, East Asia
EpiCast Report: Type 2 Diabetes - Epidemiology Forecast to 2026

EpiCast Report: Type 2 Diabetes - Epidemiology Forecast to 2026

  • $ 3995
  • Industry report
  • July 2017

EpiCast Report: Type 2 Diabetes - Epidemiology Forecast to 2026SummaryType 2 diabetes (T2D), formerly known as non-insulin dependent diabetes mellitus or adult-onset diabetes mellitus, is a chronic disorde ...

  • Industries : Chronic Disease, Pathology
  • Countries : Germany, United States, World, Spain, France, Italy, Japan, Western Europe
EpiCast Report: Chronic Obstructive Pulmonary Disease - Epidemiology Forecasts to 2025

EpiCast Report: Chronic Obstructive Pulmonary Disease - Epidemiology Forecasts to 2025

  • $ 3995
  • Industry report
  • July 2017

EpiCast Report: Chronic Obstructive Pulmonary Disease - Epidemiology Forecasts to 2025SummaryChronic obstructive pulmonary disease (COPD), also known as chronic obstructive lung disease (COLD), is a condition ...

  • Industries : Chronic Disease, Pathology
  • Countries : World, Australia, United States, Germany, Australasia, Italy, Japan, Spain, United Kingdom
Europe Atrial Fibrillation Epidemiology and Patient Flow Analysis - 2017

Europe Atrial Fibrillation Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • Industry report
  • January 2017

Fore Pharma announced the results of its Atrial Fibrillation patients study in a new report ‘Europe Atrial Fibrillation Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • Industries : Chronic Disease, Pathology
  • Countries : Europe, Germany, France, Spain, Italy, United Kingdom
Europe Allergic Rhinitis Epidemiology and Patient Flow Analysis - 2017

Europe Allergic Rhinitis Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • Industry report
  • January 2017

Fore Pharma announced the results of its Allergic Rhinitis patients study in a new report ‘Europe Allergic Rhinitis Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into ...

  • Industries : OTC, Chronic Disease, Pathology
  • Countries : Europe, Germany, France, Spain, Italy, United Kingdom
Europe Dyslipidemia Epidemiology and Patient Flow Analysis - 2017

Europe Dyslipidemia Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • Industry report
  • January 2017

Fore Pharma announced the results of its Dyslipidemia patients study in a new report ‘Europe Dyslipidemia Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Dyslipidemia ...

  • Industries : Chronic Disease, Pathology
  • Countries : Europe, Germany, France, Spain, Italy, United Kingdom
Global Plumonary Arterial Hypertension Epidemiology and Patient Flow Analysis - 2017

Global Plumonary Arterial Hypertension Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • Industry report
  • January 2017

Fore Pharma announced the results of its Plumonary Arterial Hypertension patients study in a new report ‘Global Plumonary Arterial Hypertension Epidemiology and Patient Flow Analysis - 2017’. The report ...

  • Industries : Chronic Disease, Pathology
  • Countries : World, United States, Germany, France, Spain, Italy, United Kingdom, Japan
Europe Acute Ishemic Stroke Epidemiology and Patient Flow Analysis - 2017

Europe Acute Ishemic Stroke Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • Industry report
  • January 2017

Fore Pharma announced the results of its Acute Ishemic Stroke patients study in a new report ‘Europe Acute Ishemic Stroke Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • Industries : Chronic Disease, Pathology
  • Countries : Europe, Germany, France, Spain, Italy, United Kingdom
Europe Chronic Heart Failure Epidemiology and Patient Flow Analysis - 2017

Europe Chronic Heart Failure Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • Industry report
  • January 2017

Fore Pharma announced the results of its Chronic Heart Failure patients study in a new report ‘Europe Chronic Heart Failure Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • Industries : Chronic Disease, Pathology
  • Countries : Europe, Germany, France, Spain, Italy, United Kingdom
Europe Asthma Epidemiology and Patient Flow Analysis - 2017

Europe Asthma Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • Industry report
  • January 2017

Fore Pharma announced the results of its Asthma patients study in a new report ‘Europe Asthma Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Asthma epidemiology, ...

  • Industries : Chronic Disease, Pathology
  • Countries : Europe, Germany, France, Spain, Italy, United Kingdom
Global Chronic Obstructive Pulmonary Disease Epidemiology and Patient Flow Analysis - 2017

Global Chronic Obstructive Pulmonary Disease Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • Industry report
  • January 2017

Fore Pharma announced the results of its Chronic Obstructive Pulmonary Disease patients study in a new report ‘Global Chronic Obstructive Pulmonary Disease Epidemiology and Patient Flow Analysis - 2017’. ...

  • Industries : Chronic Disease, Pathology
  • Countries : World, United States, Germany, France, Spain, Italy, United Kingdom, Japan
Europe Chronic Obstructive Pulmonary Disease Epidemiology and Patient Flow Analysis - 2017

Europe Chronic Obstructive Pulmonary Disease Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • Industry report
  • January 2017

Fore Pharma announced the results of its Chronic Obstructive Pulmonary Disease patients study in a new report ‘Europe Chronic Obstructive Pulmonary Disease Epidemiology and Patient Flow Analysis - 2017’. ...

  • Industries : Chronic Disease, Pathology
  • Countries : Europe, Germany, France, Spain, Italy, United Kingdom
Global Acute Coronary Syndrome Epidemiology and Patient Flow Analysis - 2017

Global Acute Coronary Syndrome Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • Industry report
  • January 2017

Fore Pharma announced the results of its Acute Coronary Syndrome patients study in a new report ‘Global Acute Coronary Syndrome Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • Industries : Chronic Disease, Pathology
  • Countries : World, United States, Germany, France, Spain, Italy, United Kingdom, Japan

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on